Showing results (1031-1040 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|May 10, 2018
The safety of indacaterol for the treatment of COPDEvgenios I Metaxas, Evangelos BalisExpert Opinion on Drug Safety|May 10, 2019
Muscle and statins: from toxicity to the nocebo effectJuan Pedro-Botet, Elisenda Climent, David BenaigesExpert Opinion on Drug Safety|September 30, 2017
Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillationMohammed Hasan Khan, Yogita Rochlani, Wilbert S AronowExpert Opinion on Drug Safety|October 11, 2017
A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraineStephen D SilbersteinExpert Opinion on Drug Safety|February 5, 2019
Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplaseKatleen Wyatt Chester, Megan Corrigan, J Megan Schoeffler, et al.Expert Opinion on Drug Safety|May 16, 2022
Hydroxychloroquine safety in Covid-19 vs non-Covid-19 patients: analysis of differences and potential interactionsMaría Sainz-Gil, Nieves Merino Kolly, Verónica Velasco-González, et al.Expert Opinion on Drug Safety|June 28, 2021
A review of hydroxyurea-related cutaneous adverse eventsMartin Griesshammer, Kai Wille, Parvis Sadjadian, et al.Expert Opinion on Drug Safety|June 24, 2021
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO databaseJaykaran Charan, Siddhartha Dutta, Rimplejeet Kaur, et al.Expert Opinion on Drug Safety|May 31, 2022
Actual drug-related harms in residential aged care facilities: a narrative reviewSheraz Ali, Colin M Curtain, Luke Re Bereznicki, et al.Expert Opinion on Drug Safety|January 24, 2018
Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepinesLaiana A Quagliato, Rafael C Freire, Antonio E NardiPageof 282